Submissions from 2020
Surgical Gynecologic Oncology, Nicholas Lambrou
mRECIST for HCC: Performance and novel refinements, Riccardo Lencioni
Endovascular Treatment of Giant Intracranial Aneurysms, Italo Linfante, FIU Herbert Wertheim College of Medicine Affiliates, Amy Starosciak, and Guilherme Dabus
2107 Safety and Antitumor Activity Study Evaluating Loncastuximab Tesirine and Rituximab Versus Immunochemotherapy in Diffuse Large B-Cell Lymphoma, Yuliya Linhares
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients, Murugesan Manoharan
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer, Murugesan Manoharan
Review of adjunctive midodrine to facilitate weaning intravenous vasopressors in critically ill patients, Claudia Martin Diaz, Heidi Clarke, Payal Patel, Radhan Gopalani, and Stephanie Palma
Controlled Substance Validation, Claudia Martin Diaz, Jessica Hernandez, Laura Neubauer, and Eduardo Guizan Corrales
Reconstructive Surgery and Postoperative Care for Breast Cancer, Miguel Medina and Harry Salinas
Palliative Care and Symptom Management in Breast and Gynecological Cancers, Suleyki Medina
30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL, Minesh Mehta
High-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539, Minesh Mehta
Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure, Minesh Mehta
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?, Minesh Mehta
Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia, Minesh Mehta
Radiotherapy Innovations to Optimize Brain Metastases Control, Minesh Mehta
CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA, Minesh Mehta, Rupesh Kotecha, and Yazmin Odia
CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani
HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani
Breast Cancer Surgery, Jane Mendez
Cardiac Myxoma with Cerebral Metastases and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Review, Manuel Menes and Vitaly Siomin
Validation of an MR-guided online adaptive radiotherapy (MRgoART) program: Deformation accuracy in a heterogeneous, deformable, anthropomorphic phantom, Kathryn Mittauer
A Novel Pre-plan Technique for On-table Adaptation of Pancreatic Stereotactic MR-guided Online Adaptive Radiotherapy, Kathryn Mittauer, Michael Chuong, Jessika Contreras, Diane Alvarez, Tino Romaguera, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez
Cancer-Related Cognitive Impairment: Diagnosis, Pathogenesis, and Management, Aileen Moreno, Richard Hamilton, and Beatriz Currier
Emerging Ablative and Transarterial Therapies for Pancreatic Cancer, Govindarajan Narayanan, Antonio Ucar, Ripal Gandhi, Arian Nasiri, Prasuna Inampudi, and Horacio Asbun
DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani
ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients, Yazmin Odia and Minesh Mehta
Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma, Yazmin Odia and Minesh Mehta
Early imaging marker of progressing glioblastoma: a window of opportunity, Yazmin Odia and Minesh Mehta
Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma, Yazmin Odia and Minesh Mehta
Nutritional Rehabilitation of Breast and Gynecologic Cancer Patients, Karla Otero, Claudia Ferri, and Carla Araya
The ABS brachytherapy schools, Zoubir Ouhib
The American Brachytherapy society consensus statement for skin brachytherapy, Zoubir Ouhib
Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study, Claudia Paba Prada
Case Study: How to Run Three Simultaneous Stroke Alerts that Require Endovascular Therapy, Jessilyn Pozo, Peter De Armas, Andrew Waisbrot, Daniel D'Amour, Amy Starosciak, Star Belnap, and Jayme Strauss
Triage Nursing Intervention Improves Stroke Treatment Rate and Times for Walk-in Strokes, Nayive Quezada, Ron Burke, Yaima Miro Gonzalez, Maygret Ramirez, Ivis Gonzalez, Daniel D'Amour, Amy Starosciak, Star Belnap, and Jayme Strauss
Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma, Guilherme Rabinowits
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma, Guilherme Rabinowits
Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck, Guilherme Rabinowits
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma, Guilherme Rabinowits
Design of a focused collimator for proton therapy spot scanning using Monte Carlo methods, Suresh Rana
Investigating beam matching for multi-room pencil beam scanning proton therapy, Suresh Rana and Jaafar Bennouna
Evaluation of spot size using volumetric repainting technique on a ProteusPLUS PBS Proton Therapy System, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez
Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapy, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez
Quantification of radiation and imaging isocenter coincidence of a multi-room PBS proton therapy system, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez
RADT-31. PATTERNS OF CARE IN THE USE OF ADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN LOW GRADE GLIOMA PATIENTS IN THE UNITED STATES FROM 2010-2016, Warren Rehrer, Yazmin Odia, Muni Rubens, Noah Kalman, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall
The Use of Adjuvant Radiotherapy and Chemotherapy in Low Grade Glioma Patients in the United States from 2010-2016, Warren Rehrer, Muni Rubens, Katherine Von Werne, Yazmin Odia, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall
Synoptic Report Response Options Directly Impact Patient Care, Andrew Renshaw, Troy Gatcliffe, and Edwin Gould
Principles of Radiation Therapy in Breast Cancer, Maria-Amelia Rodrigues
Definitive maxillary obturator prosthesis: Timelines for fabrication and follow-up, Evan Rosen
Definitive maxillary obturator prosthesis: Timelines for fabrication and follow-up, Evan Rosen
Dental intervention for the irradiated patient: time to re-evaluate dental treatment algorithms?, Evan Rosen
Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients, Muni Rubens
The Safety of Performing Bloodless Autologous Stem Cell Transplantation in Jehovah's Witness Patients, Muni Rubens and Yuliya Linhares
A Risk Model for Prediction of 30-day Readmission Rates After Surgical Treatment for Colon Cancer, Muni Rubens, Anshul Saxena, Chintan Bhatt, Sankalp Das, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yazmin Odia, Michael Chuong, Rupesh Kotecha, and Minesh Mehta
Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016, Muni Rubens, Anshul Saxena, Sankalp Das, Chintan Bhatt, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yuliya Linhares, Yazmin Odia, Michael Chuong, Rupesh Kotecha, and Minesh Mehta
Inpatient Palliative Care Use Among Critically Ill Brain Metastasis Patients in the United States, Muni Rubens, Anshul Saxena, Peter McGranaghan, Chintan Bhatt, Sankalp Das, Emir Veledar, Ana Viamonte Ros, Yazmin Odia, Minesh Mehta, and Rupesh Kotecha
Abstract 7078: Hospitalization for complications due to systemic therapy in the United States, Muni Rubens, Anshul Saxena, Emir Veledar, Peter McGranaghan, Belinda Boulenger, Michael Chuong, Matthew Hall, Rupesh Kotecha, and Minesh Mehta
Bioengineered Exosomal Extracellular Vesicles in Cancer Therapeutics, Marco Ruiz Andia
Revisiting Early Palliative Care for Patients With Hematologic Malignancies and Bone Marrow Transplant: Why the Delay?, Marco Ruiz Andia
Initial Validation of Proton Dose Calculations on SPR Images from DECT in Treatment Planning System, Pouya Sabouri
Abstract P338: Cardiovascular And Cerebrovascular Events Associated With Cancer Surgery In The United States, Anshul Saxena, Muni Rubens, Sankalp Das, Chintan Bhatt, Joseph Salami, Peter McGranaghan, and Emir Veledar PhD
Abstract P339: Association Between Cardiometabolic Syndrome And Cancer: Systematic Review, Anshul Saxena, Muni Rubens, Sankalp Das, Chintan Bhatt, Joseph Salami, Peter McGranaghan, and Emir Veledar
Precautions & Handling of Hazardous Chemotherapeutic Agents, Paula Sayegh
Survival Impact Of Postoperative Radiotherapy Timing In Pediatric And Young Adult Ependymoma, Sunny Shah, Kevin Gates, Chase Mallory, Muni Rubens, Haley Appel, Noah Kalman, Rupesh Kotecha, Minesh Mehta, and Matthew Hall
The Effect of a County Prehospital FAST-ED Initiative on Endovascular Treatment Times, Joseph Souchak, Ned Shashoua, Maygret Ramirez, Ivis Gonzalez, Virginia Ramos, Anshul Saxena, Emir Veledar, Amy Starosciak, and Felipe De los Rios La Rosa
Abstract 256: Length of Stay, Type of Stroke and NIHSS Score in Persons With Self-reported Diabetes, Amy Starosciak and Felipe De los Rios La Rosa
Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study, Amy Starosciak and Felipe De los Rios La Rosa
Noncontrast CT versus Perfusion-Based Core Estimation in Large Vessel Occlusion: The Blood Pressure after Endovascular Stroke Therapy Study, Amy Starosciak and Felipe De los Rios La Rosa
Thrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort Study, Amy Starosciak and Felipe De los Rios La Rosa
White Matter Disease and Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke, Amy Starosciak and Felipe De los Rios La Rosa
Implementation of Stroke Pathways to Reduce Length of Stay, Cost, Readmissions, and Mortality, Jayme Strauss, Daniel Hartnett, Peter De Armas, Albert Fernandez, Felipe De Los Rios La Rosa, Kunal Patel, Amy Starosciak, Andrew Waisbrot, Star Belnap, and Daniel D'Amour
ONS Guidelines™ for Cancer Treatment–Related Radiodermatitis, Lauren Suarez
Radiodermatitis: Clinical Summary of the ONS Guidelines™ for Cancer Treatment–Related Radiodermatitis, Lauren Suarez
Implementation of Daily Multidisciplinary Rounds on an Adult Inpatient Blood & Marrow Transplant Unit: Initial Observations and Future Plans, Vera Suzuki, Monika Magnum, Noah Zanville, and Maria Rios
Update on Oral Oncolytics: A Focus on Hematology Drugs, Monica Tadros
Evaluation of acute myeloid leukemia induction regimens in elderly patients with unfavorable risk cytogenetics that are candidates for intensive remission therapy, Monica Tadros, Guenther Koehne, Talia Zahra, Moe Shwin, Jessica Unzaga, and Nicholas Chow
Evaluating Acute Myeloid Leukemia Induction Regimens in Elderly Patients with Unfavorable Risk Cytogenetics That Are Candidates for Intensive Remission Therapy, Monica Tadros, Guenther Koehne, Talia Zahra, Jessica Unzaga, Moe Shwin, and Nicholas Chow
Dietary patterns and thyroid cancer risk: a population-based case-control study, Robert Udelsman
Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut, Robert Udelsman
Phytoestrogens and Thyroid Cancer Risk: A Population-Based Case-Control Study in Connecticut, Robert Udelsman
Polybrominated Diphenyl Ethers, Polybrominated Biphenyls, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study, Robert Udelsman
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero